Alesta Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CID-103 / CASI, Precision Autoimmune Therap
NCT07017725: A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

Recruiting
1/2
75
RoW
CID-103
CASI Pharmaceuticals, Inc.
Chronic Immune Thrombocytopenia
06/26
12/26
NCT04758767: CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma

Completed
1
10
Europe
CID-103
CASI Pharmaceuticals, Inc.
Multiple Myeloma
01/23
01/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CID-103 / CASI, Precision Autoimmune Therap
NCT07017725: A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

Recruiting
1/2
75
RoW
CID-103
CASI Pharmaceuticals, Inc.
Chronic Immune Thrombocytopenia
06/26
12/26
NCT04758767: CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma

Completed
1
10
Europe
CID-103
CASI Pharmaceuticals, Inc.
Multiple Myeloma
01/23
01/23

Download Options